SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-091356
Filing Date
2021-07-12
Accepted
2021-07-12 20:58:59
Documents
1
Period of Report
2021-06-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2122052d2_3.html 3  
1 OWNERSHIP DOCUMENT tm2122052d2_3.xml 3 2230
  Complete submission text file 0001104659-21-091356.txt   3665
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Issuer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1021 N EVERETT STREET GLENDALE CA 91207
Business Address
Horsager Alan M (Reporting) CIK: 0001871699 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39788 | Film No.: 211086606